Seasonal malaria chemoprevention: how to sustain the impact in Africa's sub-Sahel region?

30 Jan 2018
Africa Health

Over recent years, countries in the sub-Sahel of Africa have witnessed the life-saving impact of SMC. MMV discusses the challenges that remain to widespread implementation of this strategy

In some regions of the sub-Sahel of Africa, Seasonal Malaria Chemoprevention (SMC) has reduced malaria cases in children under 5 years by up to 65% during the transmission season.1 As a result of this impressive impact and with support from several organisations, implementation of SMC by the National Malaria Control Programmes in 112 of 15 eligible countries plus Togo (which was not initially identified as an eligible country but has implemented) has expanded year-on-year since 2014. The next step is to explore how to reach almost all the estimated 25 million children eligible for the intervention in all 15 eligible countries in the sub-Sahel region.3

Download the article below to continue reading.


1. ACCESS-SMC Impact: Three years of SMC in the Sahel (Publication)

2. All implementing countries: Burkina Faso, Cameroon, Chad, Ghana, Guinea, Guinea Bissau, Mali, Niger, Nigeria, The Gambia, Togo and Senegal

3. Cairns M et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun. 3:881. (2012).